For subscribers

Defeating dengue starts at home, but will hinge on scientific research

There are many promising drugs and vaccines for dengue in the pipeline, and it is worth investing in clinical trials.

Sign up now: Get ST's newsletters delivered to your inbox

There are many promising drugs and vaccines for dengue in the pipeline, and it is worth investing in clinical trials.

There are many promising drugs and vaccines for dengue in the pipeline, and it is worth investing in clinical trials.

ST PHOTO: GIN TAY

Ashley St John

Follow topic:

Even as Singapore is a leader in the fight against dengue on both the public health policy and research fronts, those of us living here find ourselves continuously challenged by

the seasonal cycles of dengue surges

.

From a broader perspective, Singapore is truly an island within the flood of dengue that inundates South-east Asia. Many Asian countries get hit far harder than we do. Bangladesh comes to mind, having met the tragic milestone in early September of

reporting its highest number of deaths in a year

, with more than 800 casualties.

See more on